MEDICA Newsletter
Social Media
More about…
- 3D-Druck
- AIDS
- Adipositas
- Akupunktur
- Allergien
- Alter
- Alternative Medizin
- Alzheimer
- Antibiotika
- Anästhesie
- Arzneimittel
- Asthma
- Augen
- Autismus
- Baby
- Behandlung
- Bildgebung
- Biochip
- Biofeedback
- Biokompatibel
- Biomarker
- Biorhythmus
- Biotechnologie
- Blase
- Blut
- Bluthochdruck
- Brust
- Chirurgie
- Darm
- Demenz
- Depression
- Desinfektion
- Deutschland
- Diabetes
- Diagnostik
- Elektronische Patientenakte
- Endoprothese
- Epilepsie
- Erbmaterial
- Ethik
- Fitness
- Forschung
- Frauen
- Früherkennung
- Geburt
- Gehirn
- Genetik
- Geräte
- Gesundheitspolitik
- Haut
- Herz
- Herz-Kreislauf
- Hygiene
- Immunsystem
- Impfkomplikation
- Impfung
- Implantat
- Infektionskrankheit
- Influenza
- Informationstechnologie
- Intensivmedizin
- Kinder
- Knie
- Kommunikation
- Kopfschmerzen
- Krankenhaus
- Krankenhausinformationssystem
- Krebs
- Labor
- Laser
- Leber
- Lunge
- MRT
- Medizinische Apps
- Mikrosystemtechnik
- Minimal-Invasiv
- Männer
- Nanotechnologie
- Neurologie
- Niere
- Notfallmedizin
- Operation
- Optimierung
- Optische Technologien
- Organe
- Orthopädie
- Parkinson
- Pathogene
- Pathologie
- Patienten
- Personalisierte Medizin
- Pflege
- Physiotherapie
- Polymere
- Prostata
- Prothese
- Psychologie
- Pädiatrie
- Qualität
- Radiologie
- Regenerative Medizin
- Rehabilitation
- Risiken
- Schlaf
- Schlaganfall
- Schmerzen
- Schwangerschaft
- Screening
- Sepsis
- Sicherheit
- Sinne
- Smart textiles
- Software
- Sport
- Stammzellen
- Sterilisation
- Telemedizin
- Therapie
- Tissue Engineering
- Transplantation
- Tuberkulose
- USA
- Ultraschall
- Vergiftung
- Video
- Virtual Reality
- Vorsorge
- Wearables
- Weltgesundheit
- Werkstoffe
- Wundheilung
- Zellen
- Ärzte
AI: mapping the brain landscape for Alzheimer's disease
16.08.2019
A team of researchers lead by Brittany Dugger of UC Davis Health has been awarded a $3.8 million grant from the National Institute for Aging (NIA) to help define the neuropathology of Alzheimer's disease in Hispanic cohorts.
Nanotechnology: better stem cell transplantation research
15.08.2019
Nanotechnology developed at Rutgers University-New Brunswick could boost research on stem cell transplantation, which may help people with Alzheimer's disease, Parkinson's disease, other neurodegenerative diseases and central nervous system injuries.
Imaging: brain's glucose consumption as a marker
08.08.2019
While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Thomas Jefferson University.
Diagnostics: new blood test for detecting Alzheimer's disease
10.07.2019
Researchers from Lund University have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.
AI could be 'game changer' in detecting and managing Alzheimer's disease
27.06.2019
Worldwide, about 44 million people are living with Alzheimer's disease (AD) or a related form of dementia. Although 82 percent of seniors in the United States say it's important to have their thinking or memory checked, only 16 percent say they receive regular cognitive assessments.
Ultrasound: restoring dopaminergic pathway at Parkinson's
11.06.2019
While there are several thousand drugs available to treat brain diseases, they cannot penetrate the blood-brain barrier (BBB) into the brain. The BBB, which protects the brain from pathogens, also prevents most drugs from gaining access to the brain functional tissue, a well-known challenge to the treatment of all brain diseases including neurodegenerative disorders like Parkinson's disease.
Diagnostic test: biomarker can diagnose Alzheimer's in its earliest stages
27.05.2019
Alzheimer's disease is the major cause of dementia and so far, no effective treatment can prevent, delay or stop its progression. We know that AD has an extensive prodromal stage (with initial symptoms preceding the disease) which lasts 15 to 20 years before clinical signs are evident. To envision an effective treatment for AD, we need to be able to accurately diagnose AD at its earliest stages.
MobiKa – programmed to help
22.05.2019
Many illnesses or old age require help with everyday tasks. Unfortunately, family members or caregivers aren’t always available to lend a hand. The MobiKa mobile service robot is designed to offer support, deliver motivation and improve the quality of life of those in need.
Functional imaging: a look at the command center
01.04.2019
All information from our body and the environment converges in our brain and is transformed into reactions in milliseconds. It is essential for medicine and research to know what our switching centre looks like. Functional methods are used to observe it more closely during work.
Functional imaging: what makes the brain tick?
01.04.2019
Our brain is the command center of our body. This is where all information and impressions are collected and converted into responses and movements. Modern imaging techniques offer physicians and researchers unique insights into the actions of the human central nervous system. The functional imaging technique allows them to watch our brain in action.